Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangjun Li

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
BMC Infectious Diseases|January 23, 2015
Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013Chao Ma, Fangjun Li, Xiang Zheng, et al.
The Lancet. Child & Adolescent Health|February 21, 2023
Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trialLidong Gao, Yan Li, Peng He, et al.
Nature Communications|May 25, 2017
TAL effector driven induction of a SWEET gene confers susceptibility to bacterial blight of cottonKevin L Cox, Fanhong Meng, Katherine E Wilkins, et al.
Vaccines|June 24, 2022
Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously with Hepatitis B Virus Vaccine, Group A Meningococcal Polysaccharide Vaccine, Measles-Rubella Combined Vaccine and Japanese Encephalitis Vaccine: A Multi-Center, Randomized, Controlled Clinical Trial in ChinaXiaodong Liu, Shaoying Chang, Ruize Wang, et al.
Cell Host & Microbe|December 4, 2014
Modulation of RNA polymerase II phosphorylation downstream of pathogen perception orchestrates plant immunityFangjun Li, Cheng Cheng, Fuhao Cui, et al.
The Lancet. Infectious Diseases|March 27, 2021
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trialsShilong Yang, Yan Li, Lianpan Dai, et al.
The New England Journal of Medicine|May 4, 2022
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in AdultsLianpan Dai, Lidong Gao, Lifeng Tao, et al.
Virologica Sinica|August 4, 2022
Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infantsZhiwei Wu, Qingliang Li, Yan Liu, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
BMC Infectious Diseases|January 23, 2015
Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013Chao Ma, Fangjun Li, Xiang Zheng, et al.
The Lancet. Child & Adolescent Health|February 21, 2023
Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trialLidong Gao, Yan Li, Peng He, et al.
Nature Communications|May 25, 2017
TAL effector driven induction of a SWEET gene confers susceptibility to bacterial blight of cottonKevin L Cox, Fanhong Meng, Katherine E Wilkins, et al.
Vaccines|June 24, 2022
Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously with Hepatitis B Virus Vaccine, Group A Meningococcal Polysaccharide Vaccine, Measles-Rubella Combined Vaccine and Japanese Encephalitis Vaccine: A Multi-Center, Randomized, Controlled Clinical Trial in ChinaXiaodong Liu, Shaoying Chang, Ruize Wang, et al.
Cell Host & Microbe|December 4, 2014
Modulation of RNA polymerase II phosphorylation downstream of pathogen perception orchestrates plant immunityFangjun Li, Cheng Cheng, Fuhao Cui, et al.
The Lancet. Infectious Diseases|March 27, 2021
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trialsShilong Yang, Yan Li, Lianpan Dai, et al.
The New England Journal of Medicine|May 4, 2022
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in AdultsLianpan Dai, Lidong Gao, Lifeng Tao, et al.
Virologica Sinica|August 4, 2022
Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infantsZhiwei Wu, Qingliang Li, Yan Liu, et al.
Pageof 6